Vagus Nerve Stimulation Paired with Tones for the Treatment of Tinnitus: A Prospective Randomized Double-blind Controlled Pilot Study in Humans

Richard Tyler, Anthony Cacace, Christina Stocking, Brent Tarver, Navzer Engineer, Jeffrey Martin, Aniruddha Deshpande, Nancy Stecker, Melissa Pereira, Michael Kilgard, Chester Burress, David Pierce, Robert Rennaker, Sven Vanneste, Richard Tyler, Anthony Cacace, Christina Stocking, Brent Tarver, Navzer Engineer, Jeffrey Martin, Aniruddha Deshpande, Nancy Stecker, Melissa Pereira, Michael Kilgard, Chester Burress, David Pierce, Robert Rennaker, Sven Vanneste

Abstract

The aim of the pilot study was to evaluate the effect of Vagus Nerve Stimulation (VNS) paired with sounds in chronic tinnitus patients. All participants were implanted and randomized to a paired VNS (n = 16) or control (n = 14) group. After 6 weeks of home therapy, all participants received paired VNS. The device was used on 96% of days with good compliance. After 6 weeks, the paired VNS group improved on the Tinnitus Handicap Inventory (THI) (p = 0.0012) compared to controls (p = 0.1561). The between-group difference was 10.3% (p = 0.3393). Fifty percent of the participants in the paired VNS group showed clinically meaningful improvements compared to 28% in controls. At one year, 50% of participants had a clinically meaningful response. The therapy had greater benefits for participants with tonal and non-blast induced tinnitus at the end of 6 (24.3% vs. 2%, p = 0.05) and 12 weeks (34% vs. 2%, p = 0.004) compared to controls with 80% and 70% responding at 6 months and 1 year, respectively. Adverse effects were mild and well-tolerated and the therapy had a similar safety profile to VNS for epilepsy. VNS paired with tones may be effective for a subgroup of tinnitus patients and provides impetus for a larger pivotal study.

Conflict of interest statement

Brent Tarver, Navzer Engineer, Chester Buress and David Pierce are employees of MicroTransponder, Inc. Michael Kilgard is a paid consultant for MicroTransponder, Inc.

Figures

Figure 1
Figure 1
Individual changes in the Tinnitus Handicap Inventory (THI) score at baseline and 6 weeks for the paired VNS group (left; n = 16) and control (right; n = 14) group. Blue lines indicate participants with blast-induced and/or tonal tinnitus (n = 6 VNS; n = 5 controls).
Figure 2
Figure 2
The THI changes at baseline, 6 and 12 weeks of treatment based on the severity of tinnitus. The severity or THI grade is generally categorized as Slight (0–16), Mild (18–36), Moderate (38–56), Severe (58–76) and Catastrophic (78–100).
Figure 3
Figure 3
Study design. Participants were implanted with the device and randomized to either a paired VNS (n = 16) or control (n = 14) group. Participants performed the treatment at home for approximately 2.5 hours/day, 7 days/week. During the first 6-weeks, the implanted control group also received VNS but was unpaired from tones. After 6 weeks of blinded, controlled treatment, participants in the control group crossed over to receive paired VNS. After 6 weeks, participants in both groups received the paired VNS stimulation and were assessed until one year.
Figure 4
Figure 4
Setup using the Serenity® System that pairs Vagus Nerve Stimulation (VNS) with tones. The inset shows the electrode lead wrapped around the cervical vagus nerve. The device is the pulse generator that is implanted under the chest wall. The implant lead connects to the pulse generator. Image courtesy of MicroTransponder, Inc.
Figure 5
Figure 5
(a) Stimulation settings for paired VNS therapy. The lower panel shows the stimulation settings (0.8 mA, 30 Hz), which overlaps with the tone. Each VNS tone pairing was presented every 30 seconds, for approximately 2.5 hrs per session over a period of 24 hrs. (b) Stimulation settings for the Unpaired (Control) group. During each session, participants received 10 minutes of tones only, 5 minutes of silence and no VNS; 2 hours of VNS only; 5 minutes of silence and no VNS, and 10 minutes of tones only.
Figure 6
Figure 6
Pure Tone Audiometry for both the paired VNS and control group. Audiograms were obtained at baseline prior to implantation. Hearing thresholds were measured at 0.5 kHz, 1 kHz, 2 kHz, 3 kHz, 4 kHz, 6 kHz, 8 kHz, and 12.5 kHz.

References

    1. Bhatt JM, Lin HW, Bhattacharyya N. Prevalence, Severity, Exposures, and Treatment Patterns of Tinnitus in the United States. JAMA Otolaryngol. Neck Surg. 2016;92697:1–7.
    1. Langguth B, Landgrebe M. Tinnitus and depression. Textb. Tinnitus. 2011;12:493–498. doi: 10.1007/978-1-60761-145-5_63.
    1. Pattyn, T. et al. Tinnitus and anxiety disorders: A review. Hear. Res. 1–11 (2015).
    1. Tyler R, et al. Development and validation of the tinnitus primary function questionnaire. Am. J. Audiol. 2014;23:260–272. doi: 10.1044/2014_AJA-13-0014.
    1. Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope. 2011;121:1555–1564. doi: 10.1002/lary.21825.
    1. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br. J. Audiol. 1993;27:7–17. doi: 10.3109/03005369309077884.
    1. Mohr, A. Your Life and Tinnitus in The Consumer Handbook on Tinnitus (ed. Tyler, R.) (Auricle Inc, 2008).
    1. Searchfield, G. Hearing Aids and Tinnitus in Tinnitus Treatment Clinical Protocols (ed. Tyler, R.) 161–75 (Thieme, 2005).
    1. Tyler R, Stocking C, Secor C, Slattery WH. Amplitude modulated S-Tones can be superior to noise for tinnitus reduction. Am. J. Audiol. 2014;23:303–308. doi: 10.1044/2014_AJA-14-0009.
    1. Tyler RS, Noble W, Coelho CB, Ji H. Tinnitus Retraining Therapy: Mixing Point and Total Masking Are Equally Effective. Ear Hear. 2012;33:588–594. doi: 10.1097/AUD.0b013e31824f2a6e.
    1. Andersson G, Kaldo V. Internet-Based Cognitive Behavioral Therapy for Tinnitus. Online. 2004;60:171–178.
    1. Sweetow RW. Cognitive aspects of tinnitus patient management. Ear Hear. 1986;7:390–396. doi: 10.1097/00003446-198612000-00008.
    1. Tyler RS, Gogel SA, Gehringer AK. Tinnitus activities treatment. Prog. Brain Res. 2007;166:425–434. doi: 10.1016/S0079-6123(07)66041-5.
    1. Dauman, R. & Tyler, R. In Tinnitus 91: Proceedings of the Fourth International Tinnitus Seminar, Bordeaux, France. August 27–30, 1991 225–229 (1992).
    1. Tyler, R. S. N. Models, P. Models, and Treatments for Tinnitus. Tinnitus Treat. Clin. Protoc. 1–22 (2006).
    1. Preece JP, Tyler RS, Noble W. The management of tinnitus. Geriatrics and Aging. 2003;6:22–28.
    1. Eggermont JJ, Roberts LE. The Neuroscience of Tinnitus: Understanding Abnormal and Normal Auditory Perception. Front. Syst. Neurosci. 2012;6:1–4. doi: 10.3389/fnsys.2012.00053.
    1. Bauer CA, Turner JG, Caspary DM, Myers KS, Brozoski TJ. Tinnitus and inferior colliculus activity in chinchillas related to three distinct patterns of cochlear trauma. J. Neurosci. Res. 2008;86:2564–2578. doi: 10.1002/jnr.21699.
    1. Eggermont JJ. Central tinnitus. Auris. Nasus. Larynx. 2003;30(Suppl):S7–12. doi: 10.1016/S0385-8146(02)00122-0.
    1. Holt AG, Bissig D, Mirza N, Rajah G, Berkowitz B. Evidence of key tinnitus-related brain regions documented by a unique combination of manganese-enhanced MRI and acoustic startle reflex testing. PLoS One. 2010;5:e14260. doi: 10.1371/journal.pone.0014260.
    1. Kaltenbach JA. The dorsal cochlear nucleus as a contributor to tinnitus: mechanisms underlying the induction of hyperactivity. Prog. Brain Res. 2007;166:89–106. doi: 10.1016/S0079-6123(07)66009-9.
    1. Noreña AJ, Eggermont JJ. Changes in spontaneous neural activity immediately after an acoustic trauma: Implications for neural correlates of tinnitus. Hear. Res. 2003;183:137–153. doi: 10.1016/S0378-5955(03)00225-9.
    1. Eggermont JJ. Tinnitus and neural plasticity (Tonndorf lecture at XIth International Tinnitus Seminar, Berlin, 2014) Hear. Res. 2015;319:1–11. doi: 10.1016/j.heares.2014.10.002.
    1. Eggermont JJ, Roberts LE. Tinnitus: animal models and findings in humans. Cell Tissue Res. 2015;361:311–36. doi: 10.1007/s00441-014-1992-8.
    1. Engineer, N. D. et al. Reversing pathological neural activity using targeted plasticity Nature470, 101–4 (2011).
    1. Engineer ND, Møller AR, Kilgard MP. Directing neural plasticity to understand and treat tinnitus. Hear. Res. 2013;295:58–66. doi: 10.1016/j.heares.2012.10.001.
    1. Hays SA, Rennaker RL, Kilgard MP. Targeting plasticity with vagus nerve stimulation to treat neurological disease. Prog. Brain Res. 2013;207:275–299. doi: 10.1016/B978-0-444-63327-9.00010-2.
    1. De Ridder D, Vanneste S, Engineer ND, Kilgard MP. Safety and efficacy of vagus nerve stimulation paired with tones for the treatment of tinnitus: A case series. Neuromodulation. 2014;17:170–179. doi: 10.1111/ner.12127.
    1. Khedr EM, Rothwell JC, Ahmed MA, El-Atar A. Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies. J. Neurol. Neurosurg. Psychiatry. 2008;79:212–215. doi: 10.1136/jnnp.2007.127712.
    1. Zeman F, et al. Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol.–Head Neck Surg. 2011;145:282–287. doi: 10.1177/0194599811403882.
    1. Meikle MB, et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. [Erratum appears in Ear Hear. 2012 May;33(3):443] Ear Hear. 2012;33:153–176. doi: 10.1097/AUD.0b013e31822f67c0.
    1. Chen, S.-P. et al. Vagus Nerve Stimulation Inhibits Cortical Spreading Depression. Pain (2015).
    1. Oldani L, Dell’Osso B, Altamura AC. Long-term effects of vagus nerve stimulation in treatment-resistant depression: A 5-year follow up case series. Brain Stimul. 2015;8:1229–1230. doi: 10.1016/j.brs.2015.08.007.
    1. Conway CR, et al. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res. - Neuroimaging. 2006;146:179–184. doi: 10.1016/j.pscychresns.2005.12.007.
    1. Golm D, Schmidt-Samoa C, Dechent P, Kröner-Herwig B. Neural correlates of tinnitus related distress: An fMRI-study. Hear. Res. 2013;295:87–99. doi: 10.1016/j.heares.2012.03.003.
    1. Joos K, van neste S, de Ridder D. Disentangling depression and distress networks in the tinnitus brain. PLoS One. 2012;7:e40544. doi: 10.1371/journal.pone.0040544.
    1. Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res. 2011;191:153–159. doi: 10.1016/j.pscychresns.2010.11.004.
    1. Vanneste S, et al. The neural correlates of tinnitus-related distress. Neuroimage. 2010;52:470–480. doi: 10.1016/j.neuroimage.2010.04.029.
    1. Staecker H, et al. Selecting appropriate dose regimens for AM-101 in the intratympanic treatment of acute inner ear tinnitus. Audiol. Neurotol. 2015;20:172–182. doi: 10.1159/000369608.
    1. van de Heyning, P. et al. Efficacy and Safety of AM-101 in the Treatment of Acute Inner Ear Tinnitus V A Double-Blind, Randomized, Placebo-Controlled Phase II Study. Otol. 101 (2014).
    1. Hoare DJ, Edmondson-Jones M, Gander PE, Hall DA. Agreement and reliability of tinnitus loudness matching and pitch likeness rating. PLoS One. 2014;9:e114553. doi: 10.1371/journal.pone.0114553.
    1. Grimonprez A, Raedt R, Baeken C, Boon P, Vonck K. Neuroscience and Biobehavioral Reviews The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies. Neurosci. Biobehav. Rev. 2015;56:26–34. doi: 10.1016/j.neubiorev.2015.06.019.
    1. Vonck K, et al. Neuroscience and Biobehavioral Reviews Vagus nerve stimulation… 25 years later! What do we know about the effects on cognition? Neurosci. Biobehav. Rev. 2014;45:63–71. doi: 10.1016/j.neubiorev.2014.05.005.
    1. Borland M, et al. Cortical map plasticity as a function of vagus nerve stimulation intensity. Brain Stimul. 2016;9:117–23. doi: 10.1016/j.brs.2015.08.018.
    1. Usami K, Kawai K, Sonoo M, Saito N. Scalp-recorded evoked potentials as a marker for afferent nerve impulse in clinical vagus nerve stimulation. Brain Stimul. 2013;6:615–623. doi: 10.1016/j.brs.2012.09.007.
    1. Dobie, R. Clinical Trials and Drug Therapy for tinnitus in Tinnitus: Theory and Management (ed. Snow, J) 266–77 (2004).
    1. Tyler, R. et al. Identifying tinnitus subgroups with cluster analysis. Am. J. Audiol. 17, (2008).
    1. Tyler, R. The psychoacoustical measurement of tinnitus in Tinnitus Handbook (ed. Tyler, R.) 149–79 (Singular Publishing Group, 2000).
    1. Tyler, R. Psychoacoustical measurement of tinnitus for treatment evaluations in New Dimensions in Otorhinolaryngology Head and Neck Surgery (ed. Myers) 455–58 (Elsevier Publishing, 1985).
    1. Beck A, Steer R, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J. Pers. Assess. 1996;67:588–597. doi: 10.1207/s15327752jpa6703_13.
    1. Spielberger C., Gorsuch R., Lushene R., Vagg P. & Jacobs G. Manual for the state-trait anxiety scale. Consulting Psychologists. SF-12 (1983).
    1. Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33. doi: 10.1097/00005650-199603000-00003.
    1. Folmer RL, et al. Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol. Head Neck Surg. 2015;141:716–22. doi: 10.1001/jamaoto.2015.1219.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner